Dashboard
Manage Tickers

ADAGAdagene Inc.

Nasdaq adagene.com


$ 2.88 $ -0.09 (-3.08 %)    

Tuesday, 25-Jun-2024 12:41:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 2.83
$ 2.88
$ 0.00 x 0
$ 0.00 x 0
$ 2.88 - $ 2.88
$ 1.10 - $ 4.38
4,673
na
154.91M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/31/2024 20:32:51

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/01/2024 16:31:03

Core News & Articles
Adagene Announced Progress, Expansion Of T...
02/09/2024 11:03:14

Interim data from additional MSS CRC patients dosed at 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab antic...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/01/2024 21:31:08

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/22/2024 21:31:12

why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session
Why TransCode Therapeutics Shares Are Trad...
01/19/2024 18:05:18

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

how-is-the-market-feeling-about-adagene
How Is The Market Feeling About Adagene?
01/18/2024 13:00:18

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 21:31:08

why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Airspan Networks Shares Are Trading Hi...
01/17/2024 18:12:57

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 17:31:12

why-is-cancer-focused-adagene-stock-plummeting-today
Why Is Cancer Focused Adagene Stock Plumme...
01/17/2024 16:38:05

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows lim...

why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket
Why DatChat Shares Are Trading Lower By Ar...
01/17/2024 13:18:56

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

adagene-announces-interim-results-from-masked-anti-ctla-4-safebody-adg126-in-combination-with-pembrolizumab-in-metastatic-microsatellite-stable-colorectal-cancer
Adagene Announces Interim Results From Mas...
01/16/2024 22:11:24

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed cli...

adagene-will-present-interim-results-of-masked-anti-ctla-4-safebody-adg126-muzastotug-in-combination-with-pembrolizumab-in-mss-crc-at-american-society-of-clinical-oncology-2024-gastrointestinal-cancers-symposium
Adagene Will Present Interim Results of Ma...
01/04/2024 10:03:13

adagene-presents-data-demonstrating-the-best-in-class-therapeutic-index-for-masked-anti-ctla-4-safebody-adg126-at-sitc-2023
Adagene Presents Data Demonstrating The Be...
11/03/2023 16:07:03

- MSS CRC case examples reinforce optimal dosing regimen in ongoing phase 2 dose expansion, with a confirmed partial response a...

adagene-announces-poster-presentation-on-optimal-dose-selection-for-masked-anti-ctla-4-safebody-adg126-at-upcoming-society-for-immunotherapy-of-cancer-38th-annual-meeting
Adagene Announces Poster Presentation On O...
10/12/2023 12:06:29

- Data reinforces mechanism of action and selection of 10 mg/kg every three weeks repeat dosing regimen with pembrolizumab in o...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
10/06/2023 17:31:07

hc-wainwright--co-reiterates-buy-on-adagene-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Adag...
10/04/2023 10:12:56

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $5 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)